All Cell Content

Bringing you the latest research surrounding the safety, efficacy and characterisation of cell & gene therapies, targeted approaches for cell line development, optimised cell media techniques, and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Industry Spotlight
Merck invests $25 million in a Kansas cell culture media plant, aiming to meet rising demand for advanced therapeutics while aligning with sustainability goals.
Edited by Ben Norris |
06 December 2023
Cell & Gene Therapy Manufacturing
Video Content
Video Q&A
Here, we discuss the crucial role of a collaborative network for gene therapy development across the UK and some of the successes seen to date.
Edited by Ben Norris |
04 December 2023
Cell & Gene Therapy Manufacturing
Industry Spotlight
While both allogeneic and autologous cell therapies have seen a recent boom, the two approaches differ in terms of scale and customisation. 
Edited by Ben Norris |
24 November 2023
Stem Cell Development & Manufacturing
Industry Spotlight
Discover advanced monitoring, environmental controls, mathematical models, PAT tools, and sensor technologies shaping the future of biopharmaceuticals
Edited by Guillaume Alonso |
21 November 2023
Upstream & Downstream Bioprocessing
Industry Spotlight
Novel applications of stem cells drive personalized medicine, tailoring treatments to each patient's unique profile. Explore groundbreaking applications for more effective, individualized therapies.
Edited by Guillaume Alonso |
13 November 2023
Cell Series, Stem Cell Development & Manufacturing
Whitepaper
08 November 2023
Cell & Gene Therapy Manufacturing
Whitepaper
08 November 2023
Cell & Gene Therapy Manufacturing
Whitepaper
08 November 2023
Cell & Gene Therapy Manufacturing
Whitepaper
08 November 2023
Cell & Gene Therapy Manufacturing
Whitepaper
08 November 2023
Cell & Gene Therapy Manufacturing

Search by Keyword

Filter by Subject Area

Cell Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)